Acute kidney injury risk factor recognition in three teaching hospitals in Ethiopia by Phillips, Lowri Angharad et al.
RESEARCH
413  June 2013, Vol. 103, No. 6  SAMJ
The high morbidity and mortality associated with 
acute kidney injury (AKI) in Ethiopia represents 
an important challenge to its health community. 
A recent initiative sponsored by the International 
Society of Nephrology’s Sister Centre Programme 
between the renal units of the University Hospital in Cardiff and 
Tikur Anebassa Hospital in Addis Ababa has the broad goal of 
significantly raising the profile of renal disease in Ethiopia. The 
specific objectives are to enhance nephrology education and to 
facilitate development of the local clinical service, particularly in 
the management of AKI. Information regarding the current needs 
and activity, which are the essential tools required for design of a 
structured plan for service, are currently lacking; the lack of available 
data for presentation to policymakers is a major obstacle to any plea 
for investment and service development.
It is known that, in many cases, AKI is reversible and self-limiting 
with supportive management and temporary support of renal 
function through dialysis. A study from Sudan demonstrated that, 
of a cohort of patients with severe acute renal failure, 60% recovered 
renal function following appropriate management.[1] However, in 
developing countries, which lack access to renal replacement therapy, 
mortality rates remain high.[2-4] Failure of active monitoring of renal 
function may lead to missed opportunities for the treatment of pre-
renal AKI which, if identified, may be reversed with appropriate 
management of fluid and electrolyte disturbances. These challenges 
are particularly apparent in Ethiopia, where nephrology services for 
the entire population of 80 million are based exclusively in Addis 
Ababa. Even within the specialist centre in Addis Ababa, access to 
dialysis for patients presenting with acute (or chronic) renal failure 
is limited, owing to the erratic supply of consumables. However, 
some patients may be referred to private dialysis facilities, treatment 
then being limited by the ability of the patient and family to raise 
the necessary funds. This limitation of access to dialysis highlights 
the importance of early identification of AKI and reversal of kidney 
injury, obviating the need for dialysis and, ultimately, reducing the 
drain on the limited resources.
Such a strategy of targeted monitoring relies on the ability to 
detect patients with risk factors for developing AKI. One important 
predisposing factor is the presence of pre-existing chronic renal 
impairment, with acute-on-chronic AKI thought to represent up to 
40% of all cases of AKI.[5] Importantly, any episode of superimposed 
dialysis-requiring AKI in patients with chronic kidney disease (CKD) 
has been shown to be associated with a very high rate of non-recovery 
of renal function.[6]
It is increasingly apparent that those diseases traditionally ascribed 
as risk factors for AKI (e.g. heart disease, hypertension and diabetes) 
in the developed world are increasing in prevalence in developing 
countries. Current estimates suggest that approximately 25% of 
South Africa (SA)’s population suffer from hypertension.[7] Similarly, 
diabetes is believed to affect 9.4 million people in Africa, with a 
prevalence of diabetic nephropathy reaching 14 - 16% in SA, 9% 
in Sudan and 6.1% in Ethiopia.[7] Previous studies of AKI in sub-
Saharan Africa have highlighted obstetric complications to be an 
important cause of AKI. In SA, pregnancy-related disorders (most 
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notably septic abortion and pre-eclampsia) are responsible for 15% 
of all cases of AKI requiring dialysis.[8] Although data regarding the 
nature of AKI in Ethiopia are limited, pregnancy-related disorders are 
similarly implicated in AKI in an Ethiopian population.[9]
In patients undergoing major surgery, postoperative AKI occurs in 
33% of patients >65 years old.[10] Pre-existing CKD is known to be a 
potent predictor of postoperative AKI and is associated with failure of 
recovery of renal function.[11] There are well-defined patient cohorts 
who are at high risk and would benefit from early identification and 
monitoring with institution of appropriate interventions to avoid 
development of AKI. The aim of the present study was to assess 
current clinical practice in terms of identification of patterns of AKI 
risk factor assessment, and relate this information to monitoring of 
renal function in patients admitted to three teaching hospitals in 
Ethiopia.
Methods
Data were collected in three teaching hospitals across Ethiopia 
(identified in the tables below as: A = Tikur Anebassa Hospital in 
Addis Ababa; B = Gondar University Hospital; C = Awassa University 
Hospital). The Tikur Anebassa is a 700-bed hospital with 110 medical 
beds. It is a tertiary referral centre for the whole of Ethiopia and has 2 
nephrologists. The hospitals at Gondar and Awassa are both teaching 
hospitals in a rural setting with no specialist nephrology services. The 
former is a 400-bed (120 medical beds) referral hospital for North-
West Ethiopia, serving a population of 5 million people, and the 
latter a 350-bed (52 medical beds) referral hospital for the Southern 
Nations, Nationalities and Peoples Region (SNNPR) of Ethiopia with 
a population of 16 million.
Cross-sectional data were gathered for patients in the medical, 
surgical and obstetrics and gynaecology wards. Data were collected 
on all in-patients from their medical records over a one-week period 
at each centre during July 2011. Patients were excluded if they were 
under the age of 16 years, if the patient records were unavailable, or if 
they had been admitted within 12 hours of the time of data collection 
(where not all patients would have been seen by a doctor.)
Risk factor monitoring
Analysis of risk factor recognition was based on two types of risk 
factor: comorbidities and nephrotoxic medications. Evidence was 
sought in documentation for specific comorbidities known to be 
associated with increased risk of AKI: heart disease, hypertension, 
diabetes mellitus, HIV, cerebrovascular disease or pre-existing CKD. 
Nephrotoxic medications were defined as angiotensin-converting 
enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs 
(NSAIDs) or aminoglycoside antibiotics (monitoring of aminoglycoside 
levels was available at each centre). Lack of documentation for 
comorbidities may reflect either a genuine lack of comorbidities, or a 
lack of enquiry and documentation; therefore, additional data were 
sought from patient records via systematic enquiry of patients’ past 
medical history.
Investigations and monitoring
Whether renal function was measured (measurement of serum 
creatinine, blood urea nitrogen or both), whether the results were 
abnormal, and whether measurement was repeated, was documented 
for each patient. In addition, it was noted whether urine output, urine 
analysis by dipstick, or blood pressure were recorded and whether 
these investigations were repeated.
Statistical analysis
Data are presented as mean ± standard deviation (range). Comparison 
between groups was performed by chi-square test, and p<0.05 taken 
to represent statistical significance.
Results
Patient characteristics and underlying diagnoses
Across the 3 centres, 366 patients were recruited. Patient demographics 
are shown in Table 1. The only significant difference between patient 
groups was the expected younger age of those in Obstetrics and 
Gynaecology (O&G) wards. Similarly, duration of hospital stay was 
no different between each centre for each clinical setting, suggesting 
a similar level of clinical dependency. Active clinical problems are 
summarised in Figs 1 - 3. The most common reason for admission to 
a medical ward was infection (Fig. 1 - 3). For those medical patients 
labelled with ‘infectious’ cause for admission, the most common 
diagnoses were HIV and TB. At each centre, the percentage of the 
infections attributed to HIV was 17% (Centre A), 52% (Centre B) 
and 39% (Centre C); and for TB, 20% (Centre A), 64% (Centre B) 
and 33% (Centre C). Almost all patients in surgical wards underwent 
surgery during their admission (Centre A − 90%, Centre B − 94%, 
Centre C − data not available). The majority of surgical procedures 
were performed electively (hospital A − 67%, hospital B − 55%, 
hospital C − data not available). The proportion of patients from the 
O&G wards categorised as obstetric cases varied between the three 
centres (Centre A − 53%, Centre B − 62%, Centre C − 82.5%).
Investigations performed
Table 2 shows the percentage of patients in whom renal function was 
monitored. There was significant variation between different centres, 
Table 1. Summary of patient age, sex and duration of hospital stay
Ward (Centre) Number of patients Age (years) % male Average length of stay (days)
Medicine (A) 45 39.7±18 49 16.9±14
Surgery (A) 51 43.5±14 53 8.5±10
O&G (A) 34 33.5±13 0 8.2±8
Medicine (B) 52 38.9±18 52 16.4±19
Surgery (B) 53 37.2±14 75 13.2±11
O&G (B) 42 29.1±9 0 14.7±17
Medicine (C) 33 40.6±20 67 6.4±6
Surgery (C) 33 38.1±20 58 4.7±4.8
O&G (C) 23 26.6±6 0 5.3±6
 
The data are shown independently for each of the hospitals (A, B and C) and for each ward setting (Medicine, Surgery and O&G). Data are presented as mean ± standard deviation.
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and across the different specialities within each centre. Patients were 
significantly more likely to have had their renal function checked if 
they were at the hospital with specialist nephrology services (Centre 
A − 75%, Centre B − 31%, Centre C − 30%) (p<0.001). In each centre, 
a statistically higher proportion of patients admitted to a medical 
ward had renal function measurements (Centres A and B p<0.0001 
and Centre C p=0.002).
The proportion of patients who had urine output and/or urinalysis 
performed was low in all centres and in all departments. There was 
no difference between each centre, nor across the departments at 
each centre, in the probability either of urine output to have been 
measured or of urinalysis to have been performed.
Blood pressure measurement was recorded for the majority of 
patients in all centres and all wards, with the exception of the surgical 
ward of one of the centres.
Recognition of risk factors
Recording of AKI risk-associated comorbidities
Evidence that systematic enquiry of a patient’s past medical history was 
most probably undertaken in medical wards in each centre, suggest a 
lack of awareness of the need for such a risk assessment outside the 
context of the general medical ward (Fig. 4). For this reason, patients 
in medical wards were more likely to have documentation of AKI 
risk-associated comorbidities in their clinical records (Table 3).
Nephrotoxic agents
The percentages of patients prescribed one or more nephrotoxic 
agents in each centre and across all wards is shown in Fig. 5. ACE 
inhibitors were most likely to have been prescribed in medical wards 
(ACE inhibitor prescription: medical patients in Centres A, B and 
C: 31%, 4%, 12%; surgical patients in Centres A, B and C: 4%, 0%, 
0%; O&G patients in Centres A, B and C: 0%, 0%, 4%; respectively). 
Prescription of aminoglycosides and NSAIDs was highest in surgical 
wards (aminoglycoside prescription: surgical patients in Centres A, 
B and C: 6%, 17%, 39%; medical patients in Centres A, B and C: 
18%, 9%, 0%; and O&G patients in Centres A, B and C: 6%, 12%, 
6%; respectively. NSAID prescription: surgical patients in Centres 
A, B and C: 27%, 41%, 58%; medical patients in Centres A, B and C: 
13%, 13%, 21%; and O&G patients in Centres A, B and C: 32%, 16%, 
44%; respectively). In the surgical wards, 5.8%, 5.6% and 33.3% of all 
patients were on a combination of aminoglycosides and NSAIDs, at 
Centres A, B and C respectively.
Relationship between risk factor assessment and 
monitoring of renal function
For the entire patient cohort from the 3 centres, patients who had 
documentation of ≥1 AKI risk factor-associated comorbidities were 
significantly more likely to have their renal function measured than 
the group for which there was no such documentation (65% v. 31% 
p<0.0001 by chi-square test). This relationship remained significant 
when calculated for each of the individual hospitals: Centre A 89% 
v. 60%, p=0.0004; Centre B 54% v. 16%, p<0.001; Centre C 43% v. 
22%, p=0.038.
The prescription of nephrotoxic agents did not influence the 
frequency of measurement of renal function, with the proportion 
of those patients who had their renal function measured being no 
different between the cohort prescribed at least one nephrotoxic 
agent and that which received no nephrotoxic agent (Table 4). 
For all departments and each centre (except Surgery, Centre A), 
the relationship between prescription of nephrotoxic agents and 
measurement of renal function was not significant. In Centre A 
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Fig. 1. Working clinical diagnoses of patients on medical wards at the each 
of the 3 centres.
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Fig. 2. Working clinical diagnoses of patients admitted to surgical wards at 
each of the 3 centres. 
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Fig. 3. Active clinical problems in O&G patients in each of the 3 centres.
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Surgery, patients who were not prescribed nephrotoxic agents were, 
surprisingly, statistically more likely to have their renal function 
measured (p=0.04).
Discussion
One key objective in reducing the incidence of AKI is the assessment 
and management of factors that place patients at risk of the condition. 
Established risk factors include comorbidities such as cardiovascular 
risk factors (hypertension, diabetes mellitus), cardiovascular disease 
and severe infections such as HIV. The aim of this study was to 
explore patterns of AKI risk factor recognition and the relationship 
with subsequent renal monitoring across 3 different teaching hospital 
centres in Ethiopia, encompassing 9 different in-patient ward settings.
The first key learning point derived from the data relates 
to the detection and documentation rates of AKI risk factors 
among departments. In general, AKI risk factor assessment and 
documentation was highest in the hospital with specialist nephrology 
services; across all 3 centres, AKI risk factor assessment was highest 
in the medical wards. There was, however, marked variation in the 
extent to which doctors actively sought to identify the presence of 
such comorbidities. While some wards aimed to ensure complete 
documentation of past medical history and comorbidities, some 
failed to enquire about relevant conditions in as much as 80% of 
patients. Failure to collect this information resulted in incomplete 
medical records, and represented a lost opportunity for identifying 
patients at high risk of developing AKI.
Failure to record all clinical details in inpatient medical notes 
is recognised as a significant problem worldwide. Contributing 
factors include limited time available for clerking new patients, 
and numerous demands placed on junior doctors responsible for 
ensuring that wards run smoothly.[12] One way to address these issues 
is to produce standardised preprinted medical admission sheets for 
junior doctors to use as prompting tools. Many studies have provided 
Table 2. Percentage of patients in whom renal function was assessed by each of the parameters indicated, in each centre and in each 
ward setting
Ward (Centre) Renal function (%) Urine output (%) Dipstick (%) BP (%)
Medicine (A) n=45 100 20 30 98
Surgery (A) n=41 74 16 25 98
O&G (A) n=34 41 6 32 100
Medicine (B) n=52 63 17 50 94
Surgery (B) n= 53 15 5 19 57
O&G (B) n=42 9 0 31 83
Medicine (C) n=33 51 6 57 61
Surgery (C) n=33 12 0 27 88
O&G (C) n=23 26 4 52 100
Table 3. Percentage of patients with 0 - 4 documented AKI risk-associated comorbidities in each centre and in each ward setting
Ward (Centre)
0  
comorbidity
1  
comorbidity
2  
comorbidities
3  
comorbidities
4 
comorbidities
Average number of 
comorbidities
Medicine (A) 7 51 29 11 2 1.5
Surgery (A) 69 25 6 0 0 0.4
O&G (A) 88 9 3 0 0 0.1
Medicine (B) 21 38 37 4 0 1.2
Surgery (B) 83 17 0 0 0 0.2
O&G (B) 86 14 0 0 0 0.1
Medicine (C) 9 61 27 3 0 1.2
Surgery (C) 88 12 0 0 0 0.1
O&G (C) 96 4 0 0 0 0
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Fig. 4. Percentage of patients in each department for whom there was no 
documented evidence of a systematic enquiry of past medical history in each 
of the 3 centres.
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evidence that preprinted pro formas for patient admission are 
effective in overcoming problems with incomplete medical records. 
Not only do these forms increase data capture,[12-14] but they also 
make the process of gathering clinical information at the point of 
admission more efficient and less time-consuming. These findings 
have been replicated in hospitals across the world, including in 
Africa.[15]
Following any risk assessment, it is also imperative that a diagnosis 
of any ‘comorbidity’ should prompt doctors to conduct renal function 
testing and monitoring. The second key message from the data 
is that documentation of AKI risk-associated comorbidities was 
associated with a greater awareness of the importance of measuring 
renal function, which suggests that Ethiopian doctors appreciate 
the importance of comorbidities as renal risk factors and the 
need for renal monitoring in affected patients. This statement 
requires qualification, however, as measurement of renal function 
was highest in those specialities (i.e. medicine) with the highest rate 
of documentation and enquiry of risk assessment, which implies 
that awareness of AKI outside the context of medical admissions is 
generally low.
While the patient’s clinical history provides one important 
risk assessment tool for AKI, it is also important to consider 
the risks associated with the treatment instituted while the 
patient is in hospital. A study conducted in an Ethiopian hospital 
has highlighted the burden of renal injury associated with the 
prescription of nephrotoxic drugs, with up to 10% of AKI directly 
ascribed to the use of nephrotoxic agents.[9] Our data, comparing 
the prescribing patterns in each of the different departments, 
revealed great variability in the frequency of prescription of 
nephrotoxic medications. ACE inhibitors were most commonly 
prescribed in medical wards, probably reflecting an older patient 
cohort and presence of cardiovascular disease. Conversely, NSAIDs 
and aminoglycosides were more frequently prescribed among 
surgical patients for management of postoperative pain relief and 
prophylaxis of postoperative infection, respectively. In general, 
patients treated with nephrotoxic agents were not identified as an 
at-risk population, and therefore were not monitored for evidence 
of deteriorating renal function; this constitutes a lost opportunity 
for identifying and managing patients at high risk of AKI. Although 
the risk of developing nephrotoxicity following NSAID use is 
reported to be relatively low, the extensive prescription of NSAIDs 
for analgesia, when alternative agents are available, places many 
patients at unnecessary risk.[16,17] It would be appropriate to review 
the choice of first-line agents in certain settings, especially for 
patients with other predisposing comorbidities. Undertaking 
careful monitoring of renal function in patients taking nephrotoxic 
medications would ensure early recognition of renal toxicity. If the 
drug is necessary, dosing intervals could be altered as appropriate 
for the degree of renal impairment.
In summary: We have demonstrated that the presence of 
important risk factors for the development of AKI frequently 
goes unrecognised. This situation is not unique to Ethiopia. The 
recent National Confidential Enquiry into Perioperative Deaths 
(NCEPOD) report on AKI in the UK suggested that 29% of 
patients did not have adequate assessment or documentation 
of the most important risk factors for AKI, and that, as in the 
current study, medication and comorbidity were among the most 
common risk factors not assessed.[5] In a country such as Ethiopia 
where access to dialysis is severely restricted, early identification 
of AKI and pre-empting the need for renal replacement therapy 
is of particular importance, and is likely to directly affect patient 
mortality. Identification of high-risk patients would be improved 
by providing education about the key risk factors associated with 
the development of AKI, and instituting protocols and systems 
whereby subgroups of high-risk patients might be targeted for 
monitoring. Understanding current practice is the key first step 
in the design of any future strategy for minimising risk. With the 
Table 4. Relationship between prescription of nephrotoxic agents and measurement of renal function
Ward (Centre)
Percentage of patients prescribed a nephrotoxic 
drug who had renal function checked
Percentage of patients not prescribed a 
nephrotoxic drug who had renal function checked p-value
Medicine (A) 100 100 n/s
Surgery (A) 56 83 0.04
O&G (A) 39 43 n/s
Medicine (B) 75 60 n/s
Surgery (B) 18 12 n/s
O&G (B) 9 10 n/s
Medicine (C) 46 50 n/s
Surgery (C) 14 8 n/s
O&G (C) 27 25 n/s
n/s = not statistically significant.
0.00
30.00
40.00
50.00
60.00
Pa
tie
nt
s 
(%
)
70.00
20.00
Department
H
os
pi
ta
l A
 
M
ed
ic
in
e
H
os
pi
ta
l A
 
Su
rg
er
y
H
os
pi
ta
l A
 
O
bs
 a
nd
 G
yn
ae
H
os
pi
ta
l B
 
M
ed
ic
in
e
H
os
pi
ta
l B
 
Su
rg
er
y
H
os
pi
ta
l B
 
O
bs
 a
nd
 G
yn
ae
H
os
pi
ta
l C
 
M
ed
ic
in
e
10.00
H
os
pi
ta
l C
 
Su
rg
er
y
H
os
pi
ta
l C
 
O
bs
 a
nd
 G
yn
ae
% on a med % ACE % Amino % NSAIDs
Fig. 5. Percentage of patients prescribed ‘nephrotoxic’ pharmacological 
agents according to department in each of the 3 centres.
418  June 2013, Vol. 103, No. 6  SAMJ
RESEARCH
data presented, and with the support of the International Society 
of Nephrology’s Sister Centre Programme, we are well placed to 
develop a platform for future learning that will disseminate key 
messages aimed at modifying medical behaviour. The provision of 
locally applicable guidelines, which can drive a self-sustaining cycle 
of audit, should ultimately have a positive effect on the prevalence 
of AKI in Ethiopia.
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